Vantage Consulting Group Inc Pfizer Inc Transaction History

Vantage Consulting Group Inc

$61.2 Million
Q2 2024

A detailed history of Vantage Consulting Group Inc transactions in Pfizer Inc stock. As of the latest transaction made, Vantage Consulting Group Inc holds 8,463 shares of PFE stock, worth $239,841. This represents 0.39% of its overall portfolio holdings.

Number of Shares

8,463

Previous 8,730 3.06%

Holding current value

$239,841

Previous $242,000 2.48%

% of portfolio

0.39%

Previous 0.36%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$25.26 - $29.6 $6,744 - $7,903	-267 Reduced 3.06%	8,463 $236,000
Q1 2024 May 15, 2024	BUY	$25.89 - $29.73 $15,378 - $17,659	594 Added 7.3%	8,730 $242,000
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $35,850 - $46,565	1,372 Added 20.28%	8,136 $234,000
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $27,533 - $32,183	858 Added 14.53%	6,764 $224,000
Q2 2023 Aug 11, 2023	SELL	$36.12 - $41.79 $6,357 - $7,355	-176 Reduced 2.89%	5,906 $216,000
Q1 2023 May 10, 2023	BUY	$39.39 - $51.28 $55,618 - $72,407	1,412 Added 30.24%	6,082 $248,000
Q4 2022 Feb 13, 2023	SELL	$41.75 - $54.5 $29,183 - $38,095	-699 Reduced 13.02%	4,670 $239,000
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $24,330 - $29,701	556 Added 11.55%	5,369 $235,000
Q2 2022 Aug 09, 2022	BUY	$46.53 - $55.17 $11,399 - $13,516	245 Added 5.36%	4,813 $252,000
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $16,287 - $20,181	-356 Reduced 7.23%	4,568 $236,000
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $17,478 - $25,908	-423 Reduced 7.91%	4,924 $291,000
Q3 2021 Nov 10, 2021	SELL	$39.25 - $50.42 $11,186 - $14,369	-285 Reduced 5.06%	5,347 $230,000
Q2 2021 Aug 11, 2021	BUY	$35.91 - $40.68 $202,245 - $229,109	5,632 New	5,632 $221,000
Q1 2021 May 14, 2021	SELL	$33.49 - $37.77 $59,310 - $66,890	-1,771 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$33.47 - $42.56 $59,275 - $75,373	1,771 New	1,771 $65,000

Others Institutions Holding PFE

# of Institutions

3,222

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $159B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vantage Consulting Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vantage Consulting Group Inc with notifications on news.

Account

Vantage Consulting Group Inc Pfizer Inc Transaction History